Epoetin alfa once every 2 weeks is effective for initiation of treatment of anemia of chronic kidney disease.

@article{Benz2007EpoetinAO,
  title={Epoetin alfa once every 2 weeks is effective for initiation of treatment of anemia of chronic kidney disease.},
  author={Robert L. Benz and Rebecca Z. Schmidt and Kathleen I. Kelly and Marsha Wolfson},
  journal={Clinical journal of the American Society of Nephrology : CJASN},
  year={2007},
  volume={2 2},
  pages={
          215-21
        }
}
There are limited data suggesting that initiation of epoetin alfa at extended dosing intervals of every 2, 3, or 4 wk may be efficacious for treating anemia in patients who have chronic kidney disease and are not on dialysis (CKD-NOD). This open-label, multicenter, single-arm study investigated the efficacy of administration of 20,000 IU of epoetin alfa once every 2 wk as initiation therapy in these patients. Adults with CKD-NOD were eligible when they had hemoglobin (Hb) <11 g/dl, GFR of 10 to… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 12 CITATIONS

Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients

  • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • 2015
VIEW 1 EXCERPT
CITES BACKGROUND

Darbepoetin alfa impact on health status in diabetes patients with kidney disease: a randomized trial.

  • Clinical journal of the American Society of Nephrology : CJASN
  • 2011
VIEW 1 EXCERPT
CITES METHODS

References

Publications referenced by this paper.
SHOWING 1-10 OF 21 REFERENCES

Cardiovascular effect of normalizing the hematocrit level during erythropoietin ther220 Clinical Journal of the American Society of

T Shoji, M Togawa, N Okada, E Imai, M Hori
  • Nephrology Clin J Am Soc Nephrol
  • 2007

Extended epoetin alfa dosing in chronic kidney disease patients: a retrospective review.

  • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • 2005
VIEW 2 EXCERPTS

Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients.

  • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • 2001